Trending Now
Latest News
Coherus reveals biosimilar launch tactics in battle against Amgen’s Neulasta
Coherus dialed up pressure on Amgen with a recent FDA approval for a Neulasta biosimilar, and now the company has unveiled its bid for...
Cabaletta raises $38M to develop CAR-T-like cell therapies for autoimmune diseases
The first two approved CAR-T therapies for blood cancers have already been on the market for more than a year, and additional products are...
More
Coherus reveals biosimilar launch tactics in battle against Amgen’s Neulasta
Coherus dialed up pressure on Amgen with a recent FDA approval for a Neulasta biosimilar, and now the company has unveiled its bid for...
Cabaletta raises $38M to develop CAR-T-like cell therapies for autoimmune diseases
The first two approved CAR-T therapies for blood cancers have already been on the market for more than a year, and additional products are...
Medtronic starts trial with Symplicity Spyral renal denervation system
Irish technology firm Medtronic has secured approval from the US Food and Drug Administration (FDA) to commence a clinical study for assessing the Symplicity...
NHS director calls for greater type 2 diabetes prevention
The NHS has called for better prevention of type 2 diabetes in order to reduce the cost of diabetes prescriptions in the...
